Copyright Reports & Markets. All rights reserved.

Global Acute Myeloid Leukemia Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Acute Myeloid Leukemia Drugs Market Overview

      • 1.1 Product Overview and Scope of Acute Myeloid Leukemia Drugs
      • 1.2 Acute Myeloid Leukemia Drugs Segment by Type
        • 1.2.1 Global Acute Myeloid Leukemia Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 DC regimen
        • 1.2.3 AVD Regimen
        • 1.2.4 VCD regimen
      • 1.3 Acute Myeloid Leukemia Drugs Segment by Application
        • 1.3.1 Acute Myeloid Leukemia Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Acute Myeloid Leukemia Drugs Market by Region
        • 1.4.1 Global Acute Myeloid Leukemia Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Acute Myeloid Leukemia Drugs Market Size
        • 1.5.1 Global Acute Myeloid Leukemia Drugs Revenue (2014-2025)
        • 1.5.2 Global Acute Myeloid Leukemia Drugs Production (2014-2025)

      2 Global Acute Myeloid Leukemia Drugs Market Competition by Manufacturers

      • 2.1 Global Acute Myeloid Leukemia Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Acute Myeloid Leukemia Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Acute Myeloid Leukemia Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Acute Myeloid Leukemia Drugs Production Sites, Area Served, Product Types
      • 2.5 Acute Myeloid Leukemia Drugs Market Competitive Situation and Trends
        • 2.5.1 Acute Myeloid Leukemia Drugs Market Concentration Rate
        • 2.5.2 Acute Myeloid Leukemia Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Acute Myeloid Leukemia Drugs Production Market Share by Regions

      • 3.1 Global Acute Myeloid Leukemia Drugs Production Market Share by Regions
      • 3.2 Global Acute Myeloid Leukemia Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Acute Myeloid Leukemia Drugs Production
        • 3.4.1 North America Acute Myeloid Leukemia Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Acute Myeloid Leukemia Drugs Production
        • 3.5.1 Europe Acute Myeloid Leukemia Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Acute Myeloid Leukemia Drugs Production (2014-2019)
        • 3.6.1 China Acute Myeloid Leukemia Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Acute Myeloid Leukemia Drugs Production (2014-2019)
        • 3.7.1 Japan Acute Myeloid Leukemia Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Acute Myeloid Leukemia Drugs Consumption by Regions

      • 4.1 Global Acute Myeloid Leukemia Drugs Consumption by Regions
      • 4.2 North America Acute Myeloid Leukemia Drugs Consumption (2014-2019)
      • 4.3 Europe Acute Myeloid Leukemia Drugs Consumption (2014-2019)
      • 4.4 China Acute Myeloid Leukemia Drugs Consumption (2014-2019)
      • 4.5 Japan Acute Myeloid Leukemia Drugs Consumption (2014-2019)

      5 Global Acute Myeloid Leukemia Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Acute Myeloid Leukemia Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Acute Myeloid Leukemia Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Acute Myeloid Leukemia Drugs Price by Type (2014-2019)
      • 5.4 Global Acute Myeloid Leukemia Drugs Production Growth by Type (2014-2019)

      6 Global Acute Myeloid Leukemia Drugs Market Analysis by Applications

      • 6.1 Global Acute Myeloid Leukemia Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Acute Myeloid Leukemia Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Acute Myeloid Leukemia Drugs Business

      • 7.1 Ambit Biosciences Corporation
        • 7.1.1 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Production Sites and Area Served
        • 7.1.2 Acute Myeloid Leukemia Drugs Product Introduction, Application and Specification
        • 7.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Celgene Corporation
        • 7.2.1 Celgene Corporation Acute Myeloid Leukemia Drugs Production Sites and Area Served
        • 7.2.2 Acute Myeloid Leukemia Drugs Product Introduction, Application and Specification
        • 7.2.3 Celgene Corporation Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Cephalon
        • 7.3.1 Cephalon Acute Myeloid Leukemia Drugs Production Sites and Area Served
        • 7.3.2 Acute Myeloid Leukemia Drugs Product Introduction, Application and Specification
        • 7.3.3 Cephalon Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Clavis Pharma
        • 7.4.1 Clavis Pharma Acute Myeloid Leukemia Drugs Production Sites and Area Served
        • 7.4.2 Acute Myeloid Leukemia Drugs Product Introduction, Application and Specification
        • 7.4.3 Clavis Pharma Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Eisai
        • 7.5.1 Eisai Acute Myeloid Leukemia Drugs Production Sites and Area Served
        • 7.5.2 Acute Myeloid Leukemia Drugs Product Introduction, Application and Specification
        • 7.5.3 Eisai Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Genzyme Corporation
        • 7.6.1 Genzyme Corporation Acute Myeloid Leukemia Drugs Production Sites and Area Served
        • 7.6.2 Acute Myeloid Leukemia Drugs Product Introduction, Application and Specification
        • 7.6.3 Genzyme Corporation Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sunesis Pharmaceuticals
        • 7.7.1 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Production Sites and Area Served
        • 7.7.2 Acute Myeloid Leukemia Drugs Product Introduction, Application and Specification
        • 7.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served

      8 Acute Myeloid Leukemia Drugs Manufacturing Cost Analysis

      • 8.1 Acute Myeloid Leukemia Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Acute Myeloid Leukemia Drugs
      • 8.4 Acute Myeloid Leukemia Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Acute Myeloid Leukemia Drugs Distributors List
      • 9.3 Acute Myeloid Leukemia Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Acute Myeloid Leukemia Drugs Market Forecast

      • 11.1 Global Acute Myeloid Leukemia Drugs Production, Revenue Forecast
        • 11.1.1 Global Acute Myeloid Leukemia Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Acute Myeloid Leukemia Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Acute Myeloid Leukemia Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Acute Myeloid Leukemia Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Acute Myeloid Leukemia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Acute Myeloid Leukemia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Acute Myeloid Leukemia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Acute Myeloid Leukemia Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Acute Myeloid Leukemia Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Acute Myeloid Leukemia Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Acute Myeloid Leukemia Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Acute Myeloid Leukemia Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Acute Myeloid Leukemia Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Acute Myeloid Leukemia Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Acute Myeloid Leukemia Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age.

        The global Acute Myeloid Leukemia Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Acute Myeloid Leukemia Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Myeloid Leukemia Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Ambit Biosciences Corporation
        Celgene Corporation
        Cephalon
        Clavis Pharma
        Eisai
        Genzyme Corporation
        Sunesis Pharmaceuticals
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        DC regimen
        AVD Regimen
        VCD regimen

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now